Tags

Type your tag names separated by a space and hit enter

Anticholinesterases in Alzheimer's disease: a modest effect on moderately severe disease.
Prescrire Int. 2003 Dec; 12(68):230-1.PI

Abstract

(1) Of the four anticholinesterases available in France for the treatment of mild to moderate Alzheimer's disease, donepezil is the reference agent. (2) Yet even donepezil is only moderately effective: only about 10% of patients show a short-lived clinical improvement. (3) Recent systematic reviews from Cochrane and NICE confirm the moderate efficacy of anticholinesterases in this setting.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

14986699

Citation

"Anticholinesterases in Alzheimer's Disease: a Modest Effect On Moderately Severe Disease." Prescrire International, vol. 12, no. 68, 2003, pp. 230-1.
Anticholinesterases in Alzheimer's disease: a modest effect on moderately severe disease. Prescrire Int. 2003;12(68):230-1.
(2003). Anticholinesterases in Alzheimer's disease: a modest effect on moderately severe disease. Prescrire International, 12(68), 230-1.
Anticholinesterases in Alzheimer's Disease: a Modest Effect On Moderately Severe Disease. Prescrire Int. 2003;12(68):230-1. PubMed PMID: 14986699.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Anticholinesterases in Alzheimer's disease: a modest effect on moderately severe disease. PY - 2004/2/28/pubmed PY - 2004/3/26/medline PY - 2004/2/28/entrez SP - 230 EP - 1 JF - Prescrire international JO - Prescrire Int VL - 12 IS - 68 N2 - (1) Of the four anticholinesterases available in France for the treatment of mild to moderate Alzheimer's disease, donepezil is the reference agent. (2) Yet even donepezil is only moderately effective: only about 10% of patients show a short-lived clinical improvement. (3) Recent systematic reviews from Cochrane and NICE confirm the moderate efficacy of anticholinesterases in this setting. SN - 1167-7422 UR - https://www.unboundmedicine.com/medline/citation/14986699/Anticholinesterases_in_Alzheimer's_disease:_a_modest_effect_on_moderately_severe_disease_ L2 - https://medlineplus.gov/alzheimersdisease.html DB - PRIME DP - Unbound Medicine ER -